|Medical School||Stanford University|
|Residency||Bascom Palmer Eye Institute at the University of Miami|
|Fellowship||University of California, San Francisco|
|Special Interest||Macular degeneration and diabetic retinopathy|
|Publications||View on PubMed|
Daniel L. Chao M.D., Ph.D., is an Assistant Professor of Ophthalmology at the Shiley Eye Institute. He is a retina surgeon, clinician-scientist, and entrepreneur. Dr. Chao earned a BS in Biomedical Engineering at Virginia Commonwealth University and an M.D. and Ph.D. in Neurosciences at Stanford University. He completed his internship at Santa Clara Valley Medical Center, his ophthalmology residency at the Bascom Palmer Eye Institute at the University of Miami, and then completed his vitreoretinal surgery fellowship at the University of California, San Francisco. He has been honored with many awards including the Heed Fellowship, and the William F. Hoyt Teaching Award and has been recognized as one of 20 Emerging Vision Scientists by the Alliance for Eye and Vision Research.
Dr. Chao’s clinical focus is in the medical and surgical treatment of retinal diseases with a special interest in macular degeneration and diabetic retinopathy, retinal detachment, and inherited retinal diseases. He is an experienced clinical researcher and principal investigator of many clinical trials investigating novel therapeutics for retinal diseases. He is involved in multiple interdisciplinary collaborations to develop novel imaging modalities and therapeutic approaches for retinal diseases.
He also serves as Director of Medical Student Education at the Shiley Eye Institute. He is responsible for preclinical instruction in ophthalmology, organization of the clinical electives, as well as advising and mentoring medical students interested in ophthalmology. He has also started an Introduction to Ophthalmology Courses for 1st and 2nd year medical students to get exposure to ophthalmology as a career.
Dr. Chao also leads a translational research program focused on developing new therapeutics and diagnostics for retinal diseases such as diabetic retinopathy and age related macular degeneration. These span diverse approaches including using mouse genetics, zebrafish models, high throughput small molecule screens, and cell culture. His long-term goal is to identify new therapeutic targets for diabetic retinopathy and macular degeneration and translate these into therapies which can help save vision for patients with these blinding diseases.
In addition, Dr. Chao is an entrepreneur and is passionate about translating discoveries from the lab and commercializing them to develop tangible products which help patients. He is an academic co-founder of a startup company developing novel therapeutics for dry macular degeneration. He also serves on the scientific advisory board for multiple early stage companies in the ophthalmology space advising on clinical development and translational research.
The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.
The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.
The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.
Click Here To Accept